|
References:
1. Statland JM, Fontaine B, Hanna MG, et al. Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve. 2018;57(4):522-530.
2. Levitt JO. Practical aspects in the management of hypokalemic periodic paralysis. J Transl Med. 2008;6:18.
|
|
This message was sent by: Strongbridge Biopharma • 900 Northbrook Drive, Suite 200 • Trevose, PA 19053
|
This message and any attachments are for the designated recipient only and may contain privileged,
proprietary, or otherwise private information. If you have received this in error, please notify the sender
immediately and delete this message. Any other use of this email is prohibited.
|
|
Unsubscribe from this list.
|
|
|
www.strongbridgebio.com
|
|
© 2019 Strongbridge Biopharma plc
|
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc.
|
|
KEV-0731 9/2019
|